Genta - Waiting For Genasense To Make Sense Trading Markets (press release), CA - In December 2003, Genta sought approval from the FDA for Genasense in the treatment of advanced melanoma, the most deadly form of skin cancer based on ...OTC:GNTA
Pregnant, two kids under five... and cancer. What would you do? guardian.co.uk, UK - Nov 29, 2008 Cancer is primarily a disease of ageing, and in the case of breast cancer - the most common cancer diagnosed during pregnancy - age works against women in ...
Drive to target specific cancers The Press Association - Testicular cancer, melanoma and Hodgkin's disease now all have 10 year survival rates of more than 80%. But only around 5% of those with pancreatic, ...
Cancer Stats Have Never Been Better CBS News, NY - Nov 25, 2008 The most common cancers have seen the most dramatic declines in new cases, according to an annual report by the NCI, the American Cancer Society and other ...
New Cancer Treatment Shrinks Pancreatic Tumor MarketWatch - Nov 23, 2008 The first person treated with the investigative protocol in 2000 had stage 4 melanoma; he remains disease-free today. Based on experience and relevant lab ...
Workers court UV danger StarPhoenix, Canada - Nov 29, 2008 It is estimated that 73600 Canadians were diagnosed with skin cancer last year, including 69000 cases of non-melanoma and 4600 cases of melanoma, ...
Source: Google News
Recent News and Articles on the Keywords: melanoma + gene + most Related to the article below (Last Update: 8/7/2008)
Behold The Pale Horse: The Genetics of Color and Cancer ScienceBlogs - The horse melanoma cell lines were established by MHS (unpublished data) [larger view]. Since none of the resulting gene products has been altered in size, ...
New Gene Therapy Kills Pancreatic Cancer Cells Science Daily (press release) - Aug 5, 2008 The cytokine used in this study was melanoma differentiation associated gene-7/interleukin-24, known as mda-7/IL-24. The dietary agent, perillyl alcohol ...OTC:CTHP - BIT:MLM
Combination Therapy Kills Pancreatic Cell Tumors In Mice ... Best Syndication, CA - Aug 6, 2008 The researchers combined POH with a gene-delivered cytokine (melanoma differentiation associated gene-7/interleukin-24, known as mda-7/IL-24) and found that ...
Pathwork First to Net FDA OK for Cancer of Unknown Primary Dx Pharmacogenomics Reporter (subscription), NY - CancerTYPE ID can identify the primary site of many types of epithelial malignancies, sarcomas, and melanomas, according to AviaraDx. ...
Putting melanoma into remission 7Online.com, NY - Jul 31, 2008 The sun is to blame for most melanomas, but doctors are now discovering a gene called KIT. It can trigger mucosal melanomas to grow in places like the mouth ...
Deciphering melanoma's genetic mysteries abc7.com, CA - Jul 14, 2008 And one of the sensible findings has been looking at the genetics of melanoma, a gene called KIT. This gene is interesting in the fact that its known to ...
Identical gene explains why some horses are white Sify, India - Jul 21, 2008 The study by Uppsala University, Sweden that proved this has a bearing on medical researches as the mutation also enhances the risk for melanoma. ...
Scientists find gene for grey horses with skin cancer Scotsman, United Kingdom - Jul 20, 2008 Dr Andersson's team also point out between 70 and 80 per cent of grey horses older than 15 have melanomas, a form of skin cancer that reduces their lifespan ...
Molecular classification of cutaneous malignant melanoma by gene expression profiling. - M Bittner, P Meltzer, Y Chen, Y Jiang, E Seftor, M … - Nature, 2000 - ncbi.nlm.nih.gov ... mbittner@nhgri.nih.gov The most common human ... Accordingly, though melanoma is thought
to present with ... identified by mathematical analysis of gene expression in ...
Gene therapy clinical trials worldwide 1989?2004?an overview - JG Med - J Gene Med, 2004 - doi.wiley.com ... infusing them into five patients with advanced melanoma. ... the feasibility of using
retroviral gene transduction in ... Cancer is by far the most common disease ...
Somatic mutations of the ?-catenin gene are frequent in mouse and human hepatocellular carcinomas - A de La Coste, B Romagnolo, P Billuart, CA Renard, … - Proceedings of the National Academy of Sciences of the …, 1998 - pubmedcentral.nih.gov ... The APC gene is the genemost commonly mutated in colorectal cancer ... activating mutations
of the ?-catenin gene recently were found in melanoma cell lines ...
The INK4a/ARF tumor suppressor: one gene?two products?two pathways - L Chin, J Pomerantz, RA DePinho - Trends in Biochemical Sciences, 1998 - Elsevier ... [5]). Mutation of the p53 gene is thought to be the most-frequent genetic alteration
in human cancers. ... 2. The familial melanomagene at 9p21. ...
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo - L Chin, J Pomerantz, D Polsky, M Jacobson, C Cohen … - Genes & Development, 1997 - Cold Spring Harbor Lab ... This study, therefore, provides the most direct in vivo experimental evidence
to date that ink4a is a melanoma suppressor gene. ...
Source: Google Scholar
Gene Changes Linked to Most Common Form of Melanoma
Summary: A new study may shed some light on why some people develop melanoma on parts of their bodies that don't get much sun. Researchers say these people often have a variation in a gene called MC1R which makes the skin sensitive to small amounts of any type of ultraviolet (UV) light.
Why it's important: Melanoma can be a deadly cancer that often strikes people in early adulthood and middle age. In 2006, an estimated 62,190 people in the United States will be diagnosed with melanoma and nearly 8,000 people will die from this cancer. Some people seem especially prone to melanoma. If doctors could identify who these people are, they might be able to take steps to reduce their risk. There are no tests available yet, but the information from this study may be a step in that direction.
What's already known: Most, though not all, melanomas are triggered by exposure to UV light, from the sun or other sources like tanning booths. But different types of melanomas seem to be linked to different amounts of UV exposure.
The least common type, which develops on the palms of the hands, soles of the feet, and internal surfaces such as the vagina and mouth, are obviously not caused by sun exposure. But high UV exposure is needed for another more common type, which typically occurs in people in their 50s and 60s in highly sun-exposed areas like the face and neck. Often, there is a lot of sun damage to the skin associated with these melanomas.
The most common type of melanoma develops on the trunk and legs of fair skinned people, who are often in their 30s and 40s. Although some UV exposure is necessary for the melanoma to develop, these areas do not get a lot of sun exposure, and the skin does not show signs of sun damage. Yet these people are prone to melanoma, which is hard to prevent because a small amount of UV exposure may be all that is needed to initiate the cancer.
These 3 types of melanomas have distinct patterns of chromosome abnormalities. The most common type, found in fair skinned people on the trunk and legs, often contains a mutation in the gene called BRAF. This is a mutation that has developed only in the cancer cells, not in other cells of the body, so it wasn't something the person inherited. Scientists think that the mutation in the BRAF gene may be responsible for the uncontrolled growth of the melanoma.
How this study was done: A team of researchers from the United States, Germany, and Italy wanted to know what makes the people with the BRAF-containing melanomas so sensitive to relatively little sun exposure, and why they develop their melanoma at such a young age. To answer this, the researchers looked at a gene called MC1R, or melanocortin-1-receptor.
MC1R helps cells make the brown pigment in our skin when we tan. Each person normally has 2 copies of this gene in each cell. In some people, either one or both copies of this gene have certain changes (called variations) that cause very fair skin, freckling, and red hair -- all of which make people more susceptible to melanoma. The researchers looked for other variations that might also make people susceptible to developing melanoma.
They examined the MC1R genes in blood samples from melanoma patients and also checked whether or not there were BRAF mutations in their melanomas. The patients were divided into 3 groups. People with 2 normal MC1R genes were placed in one group. People with one normal gene and one variation-containing gene were in a second group, and those with 2 variation-containing genes were put into the third group.
What was found: People who had 2 normal MC1R genes generally did not have BRAF mutations in their cancer. These people also generally had the kind of melanomas linked to heavy sun damage. People with a variation in only 1 of the 2 MC1R genes were 7 times more likely to have a BRAF mutation. And those with variations in both MC1R genes were 17 times more likely to have BRAF mutations. Most of the people in these last 2 groups had melanomas in non-sun damaged areas such as the trunk or legs.
The bottom line: Although the researchers don't know why these changes in MC1R cause the BRAF mutation and melanoma, they provide a clue for spotting the most susceptible people. They also help us understand why some melanomas develop on the trunk and legs of people who haven't had much sun exposure, while it takes a lot of sun exposure to cause melanomas in other people. Still, the researchers feel there is much more to learn before we can understand why melanoma develops.
Citation: "MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma." Published online in Sciencexpress www.sciencexpress.org June 29, 2006. First author: Maria Teresa Landi, National Cancer Institute.